The United States Food and Drug Administration (FDA) has announced a new framework aimed at accelerating approvals for personalized treatments for rare genetic diseases. This proposal allows drug manufacturers to rely on small, well-controlled studies instead of traditional clinical trials when those are not feasible. The goal is to provide patients with early access to treatments, even when available data is limited, with ongoing safety monitoring through post-approval requirements.
The FDA will provide clearer rules for the development of drugs based on genome and RNA editing, requiring justifications for the absence of randomized studies and the collection of evidence in real-world conditions after approval. Manufacturers will need to complete confirmatory studies and ensure patient protection, including informed consent. The new framework will initially apply to therapies based on genetic editing but could also be extended to other personalized products. The FDA anticipates an increase in applications for treatments aimed at rare diseases, maintaining unchanged manufacturing standards but allowing for faster action based on previous experiences.
The FDA will provide clearer rules for the development of drugs based on genome and RNA editing, requiring justifications for the absence of randomized studies and the collection of evidence in real-world conditions after approval. Manufacturers will need to complete confirmatory studies and ensure patient protection, including informed consent. The new framework will initially apply to therapies based on genetic editing but could also be extended to other personalized products. The FDA anticipates an increase in applications for treatments aimed at rare diseases, maintaining unchanged manufacturing standards but allowing for faster action based on previous experiences.
Sources
Latest News
14:50
Bloomberg: Russia reportedly proposed NATO return to its 1997 borders in exchange for the withdrawal of troops from Kaliningrad
14:44
UEFA Nations League: Romania's national team will find out its opponent in the promotion/relegation playoff for League B on Friday / Whom could it face
14:40
Calea Victoriei records the highest rent increase in Europe, following an annual rise of 29%
14:22
Real Madrid has reached an agreement with Arda Guler to extend his contract
14:17
MoND has begun preparations for the December 1 parade / More than 2,000 military personnel and 130 pieces of military equipment will participate
See more news